Intraocular lens market seen reaching $8.61 billion by 2035

Market Research Future projects the global intraocular lens market will grow from $4.86 billion in 2025 to $8.61 billion by 2035, driven by aging populations, rising cataract surgery volumes and demand for premium lens upgrades. The forecast points to the strongest growth in Asia-Pacific and continued value leadership in North America.

Why it matters: - The intraocular lens market is tied directly to cataract surgery volume, which is rising as populations age. - Premium lenses are creating higher-value sales in markets where patients pay extra for better vision after surgery. - Shifts to ambulatory surgery centers are changing how cataract care is delivered and how lens makers compete.

What happened: - Market Research Future projected the global intraocular lens market will reach $8.61 billion by 2035 from $4.86 billion in 2025. - The forecast implies a 5.9% compound annual growth rate from 2026 to 2035. - The market opened the forecast window at $5.14 billion in 2026. - The report said the market is being powered by cataract prevalence, premium optic upgrades and faster surgical workflows. - A free sample and customization links were published with the report: More information and Request customization.

The details: - Presbyopia-correcting, astigmatism-correcting and extended depth-of-focus lenses are gaining share because they can improve patient outcomes and reduce dependence on glasses. - In the U.S., patients typically pay an extra $1,800 to $3,500 per eye for a refractive upgrade above the Medicare-covered conventional lens. - Hydrophobic acrylic lenses generated about $3.02 billion of 2025 revenue and remain the dominant material. - Hydrophilic acrylic lenses held a 24% share in 2025. - PMMA held a 6.2% share in 2025. - Silicone held a 3.5% share in 2025. - Monofocal IOLs were the largest product segment in 2025 with a 61.5% share. - EDOF IOLs were the fastest-growing product segment at 10.2% CAGR. - Multifocal and trifocal IOLs were valued at $0.71 billion in 2025. - Toric IOLs were growing at an 8.8% CAGR. - Accommodating and adjustable IOLs were positioned as a premium category, including light-adjustable systems. - Ambulatory surgery centers accounted for 44.0% of global procedure-linked lens revenue in 2025. - Hospitals represented $1.85 billion in 2025 revenue. - Ophthalmology clinics and eye institutes were the fastest-growing end-use channel at 7.4% CAGR. - Phacoemulsification remained the dominant surgery type. - Extracapsular cataract surgery still had a role in emerging markets and public programs. - Intracapsular cataract surgery remained limited to specific complex and trauma cases.

Between the lines: - The report suggests cataract care is becoming a mix of public health volume and consumer-style premium purchasing. - North America remains a value leader because reimbursement covers standard lenses but not refractive upgrades. - Asia-Pacific is becoming the fastest-growing region because public procurement and private demand are both expanding. - Market concentration remains high, with the top five suppliers holding an estimated 74% to 80% of global revenue. - The competitive fight is increasingly about lens design, materials, delivery systems and digital workflow integration rather than basic access alone. - Alcon, Johnson & Johnson MedTech and Carl Zeiss Meditec collectively committed more than $3.1 billion to surgical R&D across 2023 to 2025.

What's next: - Market Research Future expects growth to continue through 2035 as more cataract surgeries move into ambulatory settings. - The report points to emerging opportunities in mid-tier astigmatism-correcting lenses, light-adjustable optics and drug-eluting lens platforms. - Biometry data services and digital surgical workflows are expected to become more important for refractive accuracy. - Asia-Pacific and Africa are expected to add volume growth, while North America and Europe drive premium-tier conversion. - China, India and other public health programs are likely to keep influencing pricing and procedure volumes.

The bottom line: - The intraocular lens market is shifting from a volume-driven cataract accessory market into a higher-value surgical platform shaped by premium optics, public reimbursement and faster outpatient care.